Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3.
Phosphatase of Regenerating Liver-3 (PRL-3) is associated with cancer progression and metastasis. The mechanisms that drive PRL-3's oncogenic functions are not well understood, partly due to a lack of research tools available to study this protein. We have begun to address these issues by devel...
Main Authors: | Caroline N Smith, Kyle Kihn, Zachary A Williamson, K Martin Chow, Louis B Hersh, Konstantin V Korotkov, Daniel Deredge, Jessica S Blackburn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0285964 |
Similar Items
-
Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3
by: Caroline N. Smith, et al.
Published: (2023-01-01) -
PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
by: Huizhi Zhang, et al.
Published: (2017-03-01) -
Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
by: Huizhi Zhang, et al.
Published: (2017-07-01) -
Inhibition of PRL-2·CNNM3 protein complex formation decreases breast cancer proliferation and tumor growth
by: Kostantin, E, et al.
Published: (2016) -
Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling
by: Haidong Liu, et al.
Published: (2024-03-01)